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ABSTRACT 
 
Conjugative Transfer Pathways of High-level Mupirocin Resistance and Conjugative Transfer 
Genes in Staphylococcus 
by 
Danielle Barnard 
 
To combat widespread infections caused by Staphylococcus aureus, mupirocin was introduced at 
the Veterans Affairs Medical Center, Mountain Home, Tennessee.  Soon after introduction, high-
level mupirocin-resistance emerged.  The rapid emergence was hypothesized to be due to 
conjugative transfer of the mupA resistance gene from S. epidermidis to S. aureus.  Results have 
shown that transfer of high-level mupirocin-resistance from S. aureus donors commonly occurs.  
However, transfer from naturally-occurring S. epidermidis donors was not attainable.  
Staphylococcus  epidermidis transconjugants, however, were capable of serving as donors.  
Further examination of non-transmissibility included PCR analysis of conjugative transfer genes 
(tra genes) in capable and non-capable donors.  Results confirmed that capable donors possess 
full-length copies of selected transfer genes.  Non-capable donors varied in the presence/absence 
of full-length copies of transfer genes, but none had all three genes.  The genetic differences 
among non-capable donors suggest that non-transmissibility has arisen independently in different 
strains via gene deletions and recombinations. 
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CHAPTER 1 
INTRODUCTION 
 
Pathogenic Bacteria and Antibiotic Resistance 
  Bacteria are often characterized on the basis of their ability to cause disease.  For 
example, bacteria that are considered harmful to humans, animals, or plants are called 
“pathogenic” and those that are relatively harmless are designated as “non-pathogenic” (Levy 
2002).  More specific classifications divide bacteria into three classes;  (i) non-pathogens, (ii) 
opportunistic pathogens, and (iii) primary pathogens.  Non-pathogenic bacterial species are not 
capable of causing damage to host organisms, hence these bacteria are also referred to as 
commensals.  Staphylococcus epidermidis is usually a common commensal that is considered 
part of the normal flora of human skin.  Opportunistic pathogens possess the ability to cause host 
damage and disease; however, this is not their typical or most common form of growth and 
replication.  Opportunistic pathogens cause damage to host organisms when the host is 
compromised or injured.  For example, Staphylococcus aureus is an opportunistic pathogen that 
may cause an infection if the host’s skin becomes damaged.  Primary pathogens are bacterial 
species that inflict damage and disease to the host as part of their natural survival and life cycle.  
Mycobacterium tuberculosis is a primary pathogen and resides only within an infected host 
(Miller and Day 2004). 
 The development of resistance to antibiotic therapy in pathogenic bacteria is currently 
complicating the treatment of bacterial infections.  With the discovery of antibiotics, these new 
“miracle” agents were heavily used, even when clinical symptoms were minor or infections were 
non-bacterial.  Consequently, bacteria that were universally susceptible to antibiotics in the past 
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are now resistant to at least some antibiotics and in many instances, to a large number of drugs.  
As bacteria emerged that were resistant to antimicrobial agents there was a need to quantify 
levels of resistance as a means to predict clinical outcomes.  The minimum inhibitory 
concentration (MIC) is the most frequently used method and represents an estimate of the 
smallest amount of antibacterial agent that is required to inhibit visually-detectable growth of a 
bacterial culture (Mascaretti 2003).  
 Resistance to antibacterial agents has important implications for morbidity, mortality, and 
overall health care in hospitals as well as in the community.  Bacterial resistance can be either 
natural (intrinsic) or acquired.  In acquired resistance the bacterial population is initially 
susceptible to antibacterial agents but the bacteria undergo changes, either genetically by the 
acquisition of new DNA, or generation of a chromosomal mutation, or phenotypic alterations 
involving physiologic responses.  The resultant cells show reduced susceptibility to antibacterial 
drugs.   
Staphylococcus 
Staphylococcus aureus is one of the leading causes of complications that arise after 
surgical procedure infections associated with long-term hospitalization.  Staphylococcus aureus 
is an opportunistic pathogen of human skin that can gain access to deeper tissues when the skin 
is broken.  A surgical site incision is an example of a common entry site for staphylococci.  
Patients with indwelling catheters and/or endotracheal tubes (ET) are at risk for complications by 
S. aureus (Levy 2002).  However, in more recent years patients who do not have the typical risk 
factors have presented with infections caused by more invasive strains of S. aureus.  These cases 
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are referred to as “community-acquired” infections and represent the product of evolution of 
pathogenic and drug-resistant S. aureus outside the typical hospital setting.  
MRSA and Nosocomial Infections 
Studies based on clinical isolates of S. aureus have shown that approximately 40% of 
strains are resistant to more than two antibiotics (Levy 2002).  Methicillin-resistant 
Staphylococcus aureus (MRSA) are strains that most often cause “hospital-acquired” or 
nosocomial infections as well as drug-resistant “community-acquired” infections.  Resistance to 
methicillin implies resistance to all β-lactam antibiotics, a group that includes penicillins and 
cephalosporins.  In a study that compared infections caused by MRSA to those caused by MSSA 
(methicillin-sensitive S. aureus) in several hospitals in New York City, treatment of MRSA-
infected patients was found to cost 6-10% more than treatment of infections caused by 
susceptible strains.  This difference translated to an additional cost of $2,500 to $3,700 per 
MRSA-infected patient and an annual cost of seven to ten million dollars for treating the 3,000 
MRSA-infected patients (Levy 2002).  These cost estimates are particularly alarming and 
astonishing when scaled up to a nationwide level. 
 To combat the morbidity and mortality associated with MRSA infections, many hospitals 
have initiated intense surveillance programs.  One of the first hospitals to take such an approach 
was in Perth, Australia (Skurray et al. 1988).  In Perth, medical personnel placed all new patients 
entering the hospital into an isolation area where they were tested for MRSA.  If patients were 
not colonized, they were moved to a general patient ward, but if they were colonized, they were 
placed on a ward with other colonized patients.  By employing this single measure of patient 
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isolation, the hospitals in Perth have kept the frequency of MRSA infections among the lowest in 
the world.  Today, most hospitals have programs in place to prevent the transmission of MRSA 
and other pathogens among patients. 
Mupirocin
The development of an antibiotic that could successfully eradicate the nasal carriage of S. 
aureus, including MRSA, was a desired and needed tool for the infectious disease 
armamentarium.  Hence, the antibiotic mupirocin was approved in 1988 and sold as a 2% 
ointment of mupirocin calcium (Mascaretti 2003).  Mupirocin was isolated as a natural product 
from a strain of Pseudomonas fluorescens.  The antimicrobial activity of mupirocin includes the 
inhibition of growth of staphylococci (including MRSA) and streptococci (excluding 
enterococci) at low concentrations but its effects are bactericidal at high concentrations.  
Mupirocin’s mechanism of action involves the inhibition of bacterial isoleucyl-tRNA synthetase, 
an enzyme that joins isoleucine to tRNA at its synthetically active site (Figure 1).  Mupirocin is 
an analogue of isoleucine and acts as a competitive inhibitor by binding to isoleucyl-tRNA 
synthetase.  This inhibition decreases or abolishes bacterial protein synthesis by preventing the 
incorporation of isoleucine into growing peptides (Mascaretti 2003). 
 Figure 1 Mupirocin’s Inhibition of Bacterial Protein Synthsis by Inhibiting Isoleucyl-tRNA 
Synthetase (Modified from Silvian et al. 1999) 
 
  Resistance to mupirocin was initially reported in the early 1990s in S. aureus, only two 
years after its introduction into clinical usage.  Low-level resistance was attributed to 
chromosomal mutations within the native ileS gene, whose product encodes isoleucyl-tRNA 
synthetase (Fujimura et al. 2001).  In contrast, isolates resistant to high levels of mupirocin 
contain two biochemically distinct isoleucyl-tRNA synthetase enzymes.  High-level resistant 
strains possess the native mupirocin-sensitive enzyme and an additional enzyme that is less 
sensitive to inhibition by mupirocin (Gilbart et al. 1993).  High-level resistance has usually been 
attributed to the presence of the mupA gene, a gene of unknown origin that is most often 
plasmid-borne.  The mupA gene encodes the additional isoleucyl-tRNA synthetase.  To date, 
mupirocin is the only aminoacyl-tRNA synthetase inhibitor marketed in the United States.  Due 
to mupirocin’s unique target, there was no expected or observed bacterial cross-resistance with 
other antibacterial agents.  
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Horizontal Gene Exchange 
In recent years the picture of bacterial resistance to antibiotics has become more 
complex, because bacteria have shown the capacity for horizontal gene transfer, that is the 
transfer of resistance genes both intra- and interspecifically.  With horizontal gene exchange, 
resistance can be achieved without mutation and selection processes (Walsh 2003).  Horizontal 
gene exchange also allows resistance to multiple antibiotics to be acquired rapidly as opposed to 
the highly improbable scenario of multiple resistance mutations arising rapidly within a single 
strain.   
Intercellular horizontal DNA transfer between bacteria occurs via three basic 
mechanisms; (i) transduction, (ii) transformation, and (iii) conjugation.  Transduction is a mode 
of genetic exchange between cells that is mediated by viruses (called bacteriophages).  
Bacteriophages are transducing viruses if they carry parts of a bacterial plasmid or chromosome 
from one bacterial host to another (Streips and Yasbin 2002).  Transformation is the uptake of 
exogenous DNA by living bacteria.  More specifically, exogenous DNA reaches an appropriate 
site on the bacterial cell surface, is taken through to the cytoplasm, aligned to a homologous 
region in the genome, and finally is integrated into the bacterial chromosome by homologous 
recombination (Miller and Day 2004). 
 Conjugation is a form of horizontal gene exchange that requires physical contact between 
two living bacteria.  Transfer of DNA by bacterial conjugation follows a time-line with distinct 
steps.  In staphylococci, donor bacteria must harbor a fragment of DNA that contains the 
conjugative transfer genes, a suite of genes referred to as tra genes.  Some tra genes are essential  
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for conjugation because they encode genes for synthesis and assembly of the pilus.  The pilus is 
a surface appendage that both connects and separates mating cells.  DNA is not transported 
through the entire length of the pilus, but the pilus is retracted and the recipient cell is pulled 
toward the donor cell (Miller and Day 2004).  After successful transfer of single-stranded DNA 
from donor to recipient cell, the cells separate and the recipient cell becomes a potential donor 
(termed a transconjugant).  Transferred DNA can be maintained as a plasmid or can be 
incorporated into the chromosome. 
Conjugative Transfer Genes 
The tra genes required for conjugative transfer vary in number depending on the species.  
From 15 to 35 genes have been reported in bacterial conjugative transfer systems (Streips and 
Yasbin 2002).  The tra genes have been grouped into mating pair formation (mpf) genes that are 
responsible for donor-recipient contact and DNA transfer and replication (dtr) genes.  The mpf 
genes include the genes that encode for assembly of the pilus, whereas the dtr genes encode 
proteins involved in relaxosome formation and DNA replication.  The oriT (origin of transfer) is 
also an essential element that must be present on the donor DNA to initiate transfer by 
conjugation.  Cleavage of the phosphodiester bond at the origin of transfer is accomplished by 
the action of a “nicking” enzyme encoded by the nes gene in staphylococci.  Although 
conjugation most often involves the transfer of plasmid DNA from donor to recipient cell, under 
certain circumstances chromosomal DNA can be transferred. 
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The present research is a detailed examination of intra- and interspecific conjugative 
transfer of high-level mupirocin resistance in Staphylococcus.  Staphylococcus that display high-
level mupirocin resistance have been reported to possess the plasmid pG0400, a pG01-like 
plasmid (Morton et al. 1995).  pG01, a 52 kb plasmid, belongs to a class of well-described 
conjugative plasmids that are prevalent in North American staphylococcal strains.  These 
plasmids typically encode resistance to aminoglycosides, trimethoprim, and quaternary 
ammonium compounds (Morton et al. 1995).  The observation that one conjugative mupirocin 
resistance plasmid was incompatible and could not co-reside in a bacterium with pG01 led to the 
designation of that plasmid as pG0400.  Morton et al. (1995) report that pG0400 encodes 
resistance to mupirocin but lacks several resistances encoded by pG01.  Climo et al. (1996) also 
published the sequence for nes, the gene encoding the nicking enzyme.  Some strains that harbor 
pG01 and pG0400 cannot serve as donors.  The non-transmissible phenotype has been associated 
with deletions in the some of the fifteen essential tra genes in Staphylococcus (Rogolsky and 
Gobert 1990).   
Resistance Reservoirs 
Staphylococcus epidermidis, and other coagulase-negative Staphylococcus (CNS) 
species, have been hypothesized to serve as antibiotic resistance reservoirs for S. aureus (Udo et 
al. 1992; Udo et al. 1997; Bastos et al. 1999; Thomas et al. 1999).  Although S. epidermidis is a 
commensal of human skin and nares, the ability of S. epidermidis to transfer resistances to the 
more pathogenic species, S. aureus, is of concern.  Although S. epidermidis is a hypothesized 
reservoir, the number of studies that directly address the interspecific transfer capacity of 
resistance genes are few.  For example, Udo et al. (1997) report transfer of high-level mupirocin 
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resistance from S. haemolyticus to other CNS and to a restriction-enzyme deficient strain of S. 
aureus.  This group also reported the incorporation of mupirocin resistance into the chromosome 
of CNS recipients (Udo et al. 1997).  Previous work by Archer and Scott (1991) also stated that 
the gene for high-level mupirocin resistance can become incorporated into the chromosome of 
CNS recipients.  Based on hybridization of a labeled mupA probe to a 175 kb fragment Udo et al. 
(2003) reported an apparent chromosomal location of the mupA gene in S. aureus. 
Mupirocin was introduced at the James H. Quillen Veterans Affairs Medical Center 
(VAMC), Mountain Home, Tennessee in the early 1990s where it was used therapeutically and 
prophylactically.  Subsequently, resistance to mupirocin soon emerged at the VAMC (Vasquez 
et al. 2000).  After a dramatic increase in mupirocin resistance, administrative control was placed 
on mupirocin prescriptions and mupirocin resistance declined when the selective pressure was 
controlled (Walker et al. 2004).  A goal of the current research is to assess the capabilities of 
other staphylococcal species to serve as reservoirs for mupirocin resistance.  If these reservoirs 
exist, the reemergence of mupirocin resistance in S. aureus may immediately follow 
reapplication of selection pressure by increased usage of mupirocin. 
 The ability of CNS to serve as reservoirs for resistance focuses on S. epidermidis because 
it is the most commonly isolated CNS, comprising 68-94% of CNS locally (Walker et al. 
manuscript).  There is a need to first define the term reservoir prior to determining if S. 
epidermidis meets the criteria for a resistance reservoir.  A shared niche is necessary for a 
reservoir species to transfer the resistance to a target species.  The reservoir species should also 
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possess a diversity of resistances that exceed that of the target species.  And finally, the reservoir 
species must have the capability to transfer the diversity of resistances to the target species. 
Research Approach 
The first two components of an effective reservoir have been reported by Walker et al. 
(manuscript).  Samples taken from the anterior nares of patients at the VAMC showed that S. 
aureus and S. epidermidis share a niche and are frequently co-isolated.  Staphylococcus 
epidermidis also possesses a diversity of resistances that exceeds those found in co-occurring S. 
aureus.  The third criterion that S. epidermidis must satisfy is the ability to transfer resistances to 
S. aureus.  The current research addressed the potential for S. epidermidis and other CNS to 
serve as a reservoir by focusing on the conjugative transfer pathways within and among 
staphylococcal species. 
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CHAPTER 2 
METHODS AND MATERIALS 
 
Bacterial Samples 
 All of the clinical staphylococcal strains that were used in the present study were 
obtained from a collection that is maintained by the Division of Infectious Disease, Department 
of Internal Medicine at the James H. Quillen College of Medicine of East Tennessee State 
University and the James H. Quillen Veterans Affairs Medical Center (VAMC).  Isolates were 
collected from patients at the VAMC, VAMC nursing home (VAMC-NH), and the Johnson City 
Medical Center (JCMC).  Strains RN4220/pG01 and RN4220/pG0400 were provided to Elaine 
Walker by the Network on Antimicrobial Resistance in Staphylococcus aureus.  Staphylococcus 
aureus ATCC 35556, a restriction-deficient derivative of NCTC 8325, was purchased from the 
American Type Culture Collection.  The staphylococcal strains used in conjugative transfer 
assays and PCR analyses can be seen in Table 1.  To confirm species identity, morphologically 
distinct colonies from each isolate culture were Gram stained and tube coagulase reactions were 
performed.  Coagulase-negative staphylococci (CNS) were identified to species using api 
Staph20 (bioMerieux, Durham, NC).  Methicillin resistance was determined by growth on 
Mueller-Hinton media supplemented with 4% NaCl and 6 μg/ml oxacillacin.  Susceptibility to 
mupirocin was determined by Etest (AB Biodisk, Solna, Sweden) with MIC breakpoints of:  
sensitive, MIC < 4 μg/ml; low-level resistance, MIC ≥ 4 <256 μg/ml; and high-level resistance, 
MIC ≥ 256 μg/ml.  Disk diffusion assays were used to test for resistance to seven other 
antibiotics (ciprofloxacin, clindamycin, erythromycin, gentamicin, rifampicin, tetracycline, 
trimethoprim/sulfamethoxazole [SXT]). 
Table 1 Characteristics of Staphylococcal Strains Used in Conjugative Transfer Assays and PCR 
Analyses. VAMC = James H. Quillen Veterans Affairs Medical Center; VAMC-NH = James H. Quillen 
Veterans Affairs Medical Center Nursing Home; JCMC = Johnson City Medical Center; H = High-level 
mupirocin resistance; L = Low-level mupirocin resistance; and S = sensitive to mupirocin 
Species Strain Identification # Location Year of isolation Mupirocin resistance 
1770-1 VAMC 1995 H 
1859-1 VAMC 1995 H 
2782-1 VAMC 1996 H 
2782-22 VAMC 1996 S 
3475 VAMC 1997 H 
3570-1 VAMC 1997 H 
S.
 a
ur
eu
s 3570-20 VAMC 1997 S 
4431 VAMC 1997 H 
5023 VAMC 1998 H 
5965 VAMC 1999 S 
11B1 VAMC-NH 2002 S 
22B1 VAMC-NH 2002 S 
44A1 VAMC-NH 2002 H 
44A3 VAMC-NH 2002 H 
44 JCMC 2004 H 
5A1 VAMC 2002 S 
6A2 VAMC 2002 H 
27A2 VAMC 2002 S 
30B1 VAMC 2002 S 
50A1 VAMC 2002 H 
5 JCMC 2004 H 
7 JCMC 2004 H 
8 JCMC 2004 S 
12 JCMC 2004 S 
17 JCMC 2004 H 
S.
 e
pi
de
rm
id
is
 
21 JCMC 2004 H 
22 JCMC 2004 L 
26 JCMC 2004 H 
28 JCMC 2004 H 
29 JCMC 2004 H 
34 JCMC 2004 H 
35 JCMC 2004 H 
36 JCMC 2004 H 
37 JCMC 2004 H 
41 JCMC 2004 H 
44 JCMC 2004 H 
48 JCMC 2004 S 
51 JCMC 2004 H 
20 
S. capitis N2A1 VAMC-NH 2002 H 
N
on
-S
. e
pi
de
rm
id
is 
   
   
 
C
N
S 
S. haemolyticus N34A1 VAMC-NH 2002 S 
S. lugdunesis 9 JCMC 2004 H 
S. hominis 10 JCMC 2004 H 
S. lugdunesis 15 JCMC 2004 S 
S. haemolyticus 20 JCMC 2004 S 
S. lugdunesis 31 JCMC 2004 H 
S. lugdunesis 33 JCMC 2004 H 
Conjugative Transfer Assays 
Mupirocin-susceptible strains of S. aureus and S. epidermidis were subjected to stepwise 
selection to generate selectable chromosomal resistance markers that could be used to identify 
transconjugants.  Stepwise selection first generated resistance to rifampin (32 μg/ml) followed by 
selection for resistance to fusidic acid (15 μg/ml).  High-level mupirocin-resistant staphylococcal 
strains were used as donors in conjugation matings.  High-level mupirocin-resistant donors used 
in matings included eight S. aureus strains, seven S. epidermidis strains, and three S. epidermidis 
mupirocin-resistant transconjugant strains.  Recipients marked with resistance to rifampin and 
fusidic acid included seven strains of S. aureus and three strains of S. epidermidis.  Initial 
confirmation tests of donors and recipients confirmed that donors displayed high-level mupirocin 
resistance and that recipients had selectable resistance to rifampin and fusidic acid.  
Confirmation was carried out in Mueller-Hinton media supplemented with the appropriate 
antibiotics (Figure 2).  
 
 
Figure 2 Initial Confirmation of Donor and Recipient Strains.  Growth of recipients on media 
supplemented with rifampin and fusidic acid (left), growth of donors on media supplemented 
with mupirocin (middle), and no growth of either donor or recipients on media supplemented 
with rifampin, fusidic acid, and mupirocin (right) 
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Overnight cultures of tryptic soy broth (TSB) were inoculated and incubated at 37º C.  To 
prevent the loss of mupirocin resistance, 1.5 μg/ml of mupirocin was added to the donor cultures.  
On the subsequent day, donor cultures were washed to remove mupirocin as follows. The 
cultures were centrifuged two times at 2,000 rpm for five minutes and after each centrifugation, 
the supernatant was removed and the bacterial cells were resuspended in 10 ml of TSB.  Donor 
and recipient strains were mixed in a 1 ml:3 ml donor: recipient ratio.  The entire 4 ml mixture 
was passed through a sterile 0.45 μm Millipore (HAEP 04780, Billerica, MA) filter with 
vacuum, a procedure that allowed the broth to pass through the filter, but the mixture of donor 
and recipient cells adhered to the filter.  The filter was then placed on TSA with the culture side 
up (Figure 3).  This filter mating procedure placed donor and recipient cells in physical contact 
on a solid surface (filter) with ample nutrients (TSA) to support growth.  The TSA and filter 
were then incubated overnight at 37ºC.    
 
 
 
Figure 3 Donor and Recipient Cells on Millipore Filter with Nutrient Source (TSA) 
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After overnight incubation, the filter was transferred to a tube containing 1 ml of TSB 
and vortexed vigorously to wash the cells from the filter into the TSB.  Subsequently, 25 μl of 
the resulting mixture was spread evenly on Mueller-Hinton media supplemented with mupirocin 
(16 μg/ml), rifampin (32 μg/ml), and fusidic acid (15 μg/ml) and incubated for 48 hours at 35ºC.  
Colonies that developed on the three-antibiotic plates were transferred onto TSA.  Confirmation 
of transconjugants included re-testing on the three-antibiotic selection media, coagulase testing 
to distinguish S. aureus from CNS, and disk diffusion assays to test for other resistances.  
Confirmed transconjugants were stored in skim milk and placed at -80ºC.  Conjugative transfer 
rates were determined as the ratio of transconjugants per total number of recipients used in the 
filter mating.  Therefore, to determine the number of viable cells in the recipient cultures, 
aliquots of the cultures were spread on TSA plates in a dilution series of 10-6, 10-7, and 10-8.   
A total of 16 intraspecific S. aureus conjugations and 4 intraspecific S. epidermidis 
conjugations were attempted.  Interpecific conjugations included 11 using S. aureus donors and 
S. epidermidis recipients and 16 using S. epidermidis donors and S. aureus recipients.  Six 
conjugations involved S. epidermidis transconjugant donors and recipient strains of S. aureus 
and S. epidermidis.  In conjugations involving non-S. epidermidis CNS, five non-S. epidermidis 
CNS donors, three non-S. epidermidis CNS recipients, and three non-S. epidermidis CNS 
transconjugants were used in filter matings.  The number of staphylococcal species used in 
conjugative transfer assays can be seen in Table 2. 
 
 
 
 
 
 
Table 2 Number of Staphylococci Tested as Donors and Recipients in Filter Mating 
Experiments. (Number of strains), nd = not done 
   
Recipients 
 
S. aureus 
(7) 
S.epidermidis 
(3) 
non-S. epidermidis 
CNS (3) 
  
S. aureus (8) 16 11 nd 
S. epidermidis (7) 16 4 nd 
S. epidermidis  3 3 6 
D
on
or
s 
Transconjugants (3) 
non-S. epidermidis CNS 
(5) 
15 10 nd 
non-S. epidermidis CNS 6 3 nd 
transconjugants (3) 
 
 
 
Restriction-Deficient Recipient 
 A restriction-deficient recipient was used in conjugative transfer assays to determine 
whether non-transmissibility was a result of a restriction-modification system in recipient strains 
that degraded donor DNA.  Strains that were judged unable to serve as donors in the matings 
listed in Table 2 were tested with a restriction-deficient recipient strain (S. aureus ATCC 35556).  
The procedure used was the standard conjugative transfer assay described previously. 
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Pre-exposure to a β-lactam Agent 
 The goal of this experiment was to determine whether strains that were found to be 
unable to serve as recipients under standard conditions could be induced to become capable 
recipients.  Strains that were unable to serve as recipients with several donors were exposed to a 
β-lactam agent (oxacillin) in the overnight cultures.  Oxacillin was added to the TSB before the 
recipient cells were inoculated.    The approach is based on knowledge that β-lactam agents 
interfere with bacterial cell wall synthesis and at low concentrations increase cell membrane 
permeability (Walsh 2003).  Because increased permeability is hypothesized to facilitate 
conjugal transfer, the β-lactam pre-treatment may result in the induction of capable recipients.  
Each recipient was subjected to three pre-treatments:  (i) no oxacillin, (ii) 0.1 μg/ml oxacillin, 
and (iii) 6 μg/ml oxacillin.  After over-night growth in pre-treatment medium, cells were 
centrifuged two times at 2,000 rpm for five minutes and resuspended in 10 ml of TSB to remove 
oxacillin.  The pre-treated recipients and capable donors were assayed for successful conjugation 
using the standard conjugative transfer procedure previously described. 
PCR DNA Preparations 
 DNA was isolated using boiling mini-preparations (Nunes et al. 1999).  A 10 μl loop of 
bacteria was suspended in 500 μl of TE.  The suspension was boiled for five minutes and then 
spun for ten minutes at 14,000 x g.  The supernatant was transferred to a new tube and vortexed 
to resuspend the any remaining bacterial cells.  The centrifugation step was repeated and the 
entire volume of supernatant was transferred to a new tube. 
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PCR Primers 
 PCR primers used to amplify the mupA gene had previously been designed and used in a 
study conducted by the Infectious Diseases Lab at the VAMC.  Primer sequences were:  mup1 5’ 
GTT TAT CTT CTG ATG CTG AG 3’; mup2  5’ CCC CAG TTA CAC CGA TAT AA  3’.  
Primers for the nes (nicking enzyme of staphylococcus) gene were designed based on the 
sequence published in Climo et al. (1996) (GenBank accession number NC 005024).  The nes 
primers amplified an expected product of 241 nucleotides within the 1,997 nucleotide sequence 
of the nes gene.  The sequence was found in GenBank of the National Center for Biotechnology 
Information (NCBI) website (http://www.ncbi.nlm.nih.gov/), converted to the FASTA format 
(containing only the nucleotide sequence), and “pasted” into the PCR primer pair selection 
program, “Primer3 Input” (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).  The 
program has a default setting, but components such as the product size, the primer size, the GC 
content, and the maximum 3’ self complementarity are user-specified.   
 In the current study the guidelines for designing primers were:  primers between 19-24 
nucleotides in length; members of primer pairs with similar melting temperatures (Tm); no 
complementarity at the 3’ ends; no palindromic sequence; and the distance between the primers 
should be between 150-500 base pairs (Miesfeld 1999).  Primer sequences were synthesized at 
the Molecular Biology Core Facility of the James H. Quillen College of Medicine. 
  PCR primers were designed using the above procedure for the rpoB (RNA polymerase, 
β-subunit) gene.  The DNA sequence was obtained from Drancourt and Raoult (2002) (GenBank 
accession number X64172).  The rpoB PCR product was intended to be used as a positive PCR 
control because of its reported conservation among staphylococcal species.  Primers were also 
designed for two of the essential conjugative transfer genes, traA and traK, based on sequences 
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obtained from Firth et al. (1993) (GenBank accession number NC 005024).  The traA primers 
amplified an expected product of 241 nucleotides within the 988 nucleotide sequence of the traA 
gene and the traK primers amplified a 174 product within the 1,640 nucleotide sequence of traK.  
The transfer genes, nes, traA, and traK, were chosen because all three were reported to be 
conserved among staphylococcal species.  Moreover, the three genes are physically separated on 
the hypothesized pG01-like plasmid and separates the transfer region of the plasmid into 
approximate thirds. 
 
PCR Reactions and Conditions 
 All PCR reactions were carried out in a total volume of 25 μl.  PCR reagents and volumes 
included:  22.5 μl of PCR Supermix (Invitrogen, Carlsbad, CA), 0.5 μl each of the forward and 
reverse primers, 1.0 μl of dH20, and 0.5 μl of the bacterial DNA.  The PCR cycling reaction was 
conducted in a Perkin Elmer 9600 (Norwalk, CT) GeneAmp machine.  The cycling conditions 
for the nes and mupA genes were as follows:  1 denaturation cycle [94ºC,10’]; followed by 30 
amplification cycles [94ºC, 30”; 50ºC, 30”; 72ºC, 30”]; followed by 1 extension cycle [72ºC, 7”]; 
followed by [4ºC, indefinitely].  The rpoB primers were used with an annealing temperature of 
52°C, instead of 50ºC.  The traA primers were subjected to a 54ºC annealing temperature and an 
annealing temperature of 59ºC was used for traK primers.  Table 3 shows all primer sequences, 
annealing temperatures, and number of cycles for each target gene.  All PCR reactions were 
assayed on 1% Seakem GTG : 1% NuSeive agarose gels (Cambrex Bioscience Rockland Inc., 
Rockland, ME).   
DNA size markers included λ Hind III and a 100 base-pair ladder (Promega, Madison, WI) to 
estimate the size of the PCR products.  The resultant bands were visualized by ethidium bromide 
fluorescence and analyzed visually. 
 
 
 
Table 3 Primers Used in PCR Analysis 
 
Gene  Primers Sequence (5’-3’)  Annealing Temp. Cycles 
 
mupA  M   GTT TAT CTT CTG ATG CTG AG 50°C  30 1
  M 50ºC   CCC CAG TTA CAC CGA TAT AA2   
 
nes  nes TTC GTG CTT TCC AAC CTT CT 50ºC  30 Left  
  nesRight  AAC CTA AGC GAA AGG GCA AT 50ºC   
 
rpoB  rpoB GCI ACI TGI TCC ATA CCT GT 52°C  35 Reverse 
  rpoB AAC CAA TTC CGT ATI GGT TT 52°C   forward 
 
traA  traA   CTC GGG ACA AAT AGC AAT GG 54°C  35 Left
  traARight GCC TCC TCA AAA GTG TCA GC 54°C   
 
traK  traK   TGG TTT TGC AGT ATC AGA AGG A 59°C  35 Left
traKRight CCC AAA ACT GGC AAC ATT ACA 59°C   
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CHAPTER 3 
RESULTS 
 
Conjugations Involving S. aureus and S. epidermidis 
 A summary of conjugative transfer of specific donor-recipient combinations can be seen 
in Table 4.  The frequency of successful intra- and interspecific conjugative transfer of high-
level mupirocin resistance for mating pair combinations involving S. aureus and S. epidermidis 
can be seen in Table 5.  Staphylococcus aureus donated high-level mupirocin resistance to S. 
aureus and S. epidermidis recipients with similar success frequencies (χ2 = 1.40; P = 0.24; Table 
6). 
 In a surprising result, all 28 naturally-occurring isolates of S. epidermidis were unable to 
serve as donors in intra- and interspecific conjugations.  However, all three transconjugants of S. 
epidermidis were able to donate mupirocin resistance to S. aureus and S. epidermidis recipients.  
Three S. aureus strains (JCMC 44, VANH-44A3, and VANH-44A1) were found to be incapable 
of serving as donors to either S. aureus or S. epidermidis recipients (Table 4), demonstrating a 
difference in donor strain capabilities within S. aureus.  All three non-capable S. aureus donors 
were isolated relatively recently (late 2002-2004) whereas capable donors were isolated in 
earlier years (1996-1998) representing a significant temporal influence on donor ability (χ2 = 8.0; 
P = 0.018; Table 7).  Strains of S. aureus that were incapable of serving as recipients were also 
identified (S. aureus 3570-20 and S. aureus 5965).  In contrast all three strains of S. epidermidis 
that were tested were capable recipients (Table 4).  A pictorial summary of conjugative transfer 
pathways can be seen in Figure 4. 
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Table 4 Intra- and Interspecific Conjugative Transfer of Mupirocin Resistance.  “√” indicates 
successful conjugations and “X” indicates unsuccessful conjugations.  T.C. = S. epidermidis 
transconjugant having received high-level mupirocin resistance from S. aureus  
 
 
  
Recipients S. aureus S. epidermidis 
 
D
on
or
s 
 2782
-22 
8325 22B1 3570
-20 
ATCC 
35556 
5965 11B1 5A1 27A2 30B1 
 
 
Donor 
Efficiency 
 
3570-1 
 
√ 
 
X 
 
√ 
 
X 
 
√ 
 
X 
  
√ 
 
√ 
  
5/8 
3475 √  √ X √ X  √ √  5/5 
2782-1        √ √  2/2 
JCMC-44   X  X   X   0/3 
VANH-
44A3 
  X     X    
0/2 
VANH-
44A1 
  X  X   X    
0/3 
4431   √     √   2/2 
S.
 a
ur
eu
s 
5023   √     √   2/2 
 
6A2 
    
X 
 
X 
    
X 
  
0/3 
50A1    X X    X  0/3 
JCMC-7  X  X X    X  0/4 
JCMC-17  X   X      0/2 
JCMC-29  X   X      0/2 
JCMC-35  X  X X    X  0/4 S
. e
pi
de
rm
id
is
 
JCMC-34  X   X      0/2 
27A2-TC        
√ 
   
√ 
 
2/2 
30B1-TC2       √   √ 2/2 T.
C
. 
5A1-TC       √   √ 2/2 
 Recipient 
Efficiency 
 
2/2 
 
0/6 
 
4/7 
 
0/6 
 
2/11 
 
0/2 
 
3/3 
 
5/8 
 
3/7 
 
3/3 
 
 
Table 5 Summary of Conjugative Transfers for Donor and Recipient Combinations Involving S. 
aureus and S. epidermidis.  Each attempt represents a different donor-recipient combination 
 
 
  Recipient  
S. aureus S. epidermidis Donor  
 
   S. aureus 8/18 = 44% 8/11 = 72%   
 
    S. epidermidis 0/16 = 0% 0/4 = 0%       S. epidermidis 3/3 = 100% 3/3 = 100%  
Transconjugants  
  
 
 
 
Table 6 2 x 2 Contingency Table Showing Similar Frequencies of Successful Conjugative 
Transfer of High-level Mupirocin Resistance from S. aureus Donors to S. aureus and S. 
epidermidis Recipients 
 
 
    
Recipients Successful Not Successful % Successful 
 
S. aureus 8 8 50 
 
 
S. epidermidis 8 3 73 
 
2   χ  = 1.40; P = 0.24 
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Table 7 2 x 2 Contingency Table Showing Temporal Influence on Capabilities of Recent (2002-
2004) and Earlier (1996-1998) S. aureus Donors 
  
 
    
S. aureus Donors Capable Non-capable % Capable 
 
Recent (2002-2004) 0 3 0 
 
 
Earlier (1996-1998) 5 0 100 
 
2   χ  = 8.0; P = 0.018 
 
 
 
 
 
 
 
 
S. epidermidis 
S. aureus 
S. epidermidis 
S. aureus 
S. aureus
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Summary of Conjugative Transfer Pathways (green arrows represent successful transfer 
of mupA gene and red arrows represent unsuccessful transfer of mupA gene) 
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Antibiotic resistance testing of donor, recipient, and transconjugant strains using disk 
diffusion assays showed that gentamicin resistance co-transferred with mupirocin resistance in 
78% of conjugations in which the donor strains were resistant to both mupirocin and gentamicin 
and the recipient strains were sensitive to both (Table 8).  Transfer of mupirocin resistance from 
two donors (S. aureus 4431 and S. aureus 5023) that were resistant to mupirocin but sensitive to 
gentamicin demonstrated that gentamicin resistance was not essential for conjugative transfer of 
mupirocin resistance. 
 
 
 
 
Table 8 Association Between Transfer of High-level Mupirocin Resistance and Gentamicin 
Resistance.  Recipients were sensitive to both antibiotics.  (mup = mupirocin, gen = gentamicin; 
R = resistant, S = sensitive)    
 
 
   
 Transconjugants   
  R
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  mup  genR Rmup  genS
   
Rmup  genR 14 4 
D
on
or
 
   
   
Rmup  genS - 4 
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Conjugations Involving Non-S. epidermidis CNS  
To assess the transmissibility of mupirocin resistance to and from coagulase-negative 
staphylococcus (CNS) species other than S. epidermidis, conjugations were conducted using 
three non-S. epidermidis CNS species (S. capitis N2A1, S. hominis 10, and S. lugdunesis 9, 31, 
and 33) as donors and two non-S. epidermidis CNS species (S. lugdunesis 15 and S. 
haemolyticus 20 and N34A1) as recipients.  Transmission pathways of mupirocin resistance to 
and from these CNS were similar to pathways in S. epidermidis.  That is, naturally-occurring 
high-level mupirocin-resistant CNS were incapable of serving as donors to either S. aureus or S. 
epidermidis, but transconjugant CNS were capable of transferring mupirocin resistance to other 
staphylococcal species (Table 9).  A summary of the relative efficiency of CNS donors and 
recipients can be seen in Table 10.   
 
Table 9 Transmission of Mupirocin Resistance From Various Donor-Recipient Combinations in 
which CNS Served as Donors.  “√” indicates successful transfer and “X” indicates unsuccessful 
transfer.  S. cap = S. capitis, S. lugd = S. lugdunesis, S. hom = S. hominis.  T.C. = S. epidermidis 
and non-S. epidermidis transconjugant having received high-level mupirocin  
resistance from S. aureus  
 Recipients 
   
S. aureus S. epidermidis Non- S. epidermidis CNS 
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  8325 22B1 ATCC 5A1 27A2 S.lugd 
15 
S.haem S.haem 
35556 20 N34A1 
 Donors 
S. cap 
N2A1 
X X X X X    
S. lugd 
9 
X X X X X    
S. lugd 
31 
X X X X X    
 
N
on
- S
. e
pi
de
rm
id
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 C
N
S 
S. lugd X X X X X    
33 
S. hom X X X X X    
10 
 
S. e       √ X √ 
27A2TC  
S.
 e
 
T.
C
. 
S.e 5A1TC      √ √ √ 
S. lugd 
15TC 
 √ √ √     
N
on
- S
. 
ep
id
er
m
id
is
 C
N
S 
S. haem  √ √ √  
20TC 
   
T.
C
 
S. haem  √ √ √     
N34A1TC 
 
Table 10 Summary of Conjugative Transfer for Donor and Recipient Species Combinations 
Involving CNS.  “na” indicates that the donor and recipient combination was not attempted 
  
 
Recipients 
 
  Non-S. epidermidis 
CNS S. epidermidisS. aureus Donor (2) (3) (3)    
 Donor Total 
     
0/15 = 0% Non-S. epidermidis 
CNS (5) 
0/10 = 0% na 0/15 = 0% 
 
 
     
S. epidermidis 
Transconjugants (2) 
3/3 = 100% 3/3 = 100% 5/6 = 83% 11/12 = 
88% 
 
     
Non-S. epidermidis 
CNS (3) 
6/6 = 100% 3/3 = 100% na 9/9 = 100% 
Transconjugants 
 
 
 
 
Restriction-Deficient Recipient  
Attempts to transfer mupirocin resistance from strains judged as non-capable donors in 
trials using naturally-occurring recipient strains into a restriction-deficient recipient strain 
(ATCC 35556) were all unsuccessful (Tables 4 and 9).  These trials included two S. aureus, 
seven S. epidermidis, and five non-S. epidermidis CNS. 
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Pre-exposure of Recipients to a β-lactam Agent 
Pre-exposure of strains incapable of serving as recipients in prior tests (S.a. 3570-20 and 
S.a. 5965) to a β-lactam agent (oxacillin) did not result in the recovery of transconjugants (Table 
11).  Exposure of a capable recipient (S. aureus 22B1) to a β-lactam agent, however, increased 
the efficiency of conjugative transfer 14 to 20 fold at higher concentrations of oxacillin (6 
µg/ml).  
 
 
Table 11 Results of Pre-Exposure of Recipients to Oxacillin. “X” indicates unsuccessful transfer. 
Entries represent conjugative transfer efficiencies 
  
 Recipients 
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 S. a. 3570-20 S. a. 5965 S. a. 22B1  
Oxa. Conc. 
(µg/ml) 0 0.1 6 0 0.1 6 0 0.1 6 
 
 
S.a .3570-1 
 
 
X X X X -8X X 5.6x10 5.0x10-8 1.1x10-6
D
on
or
s 
 
 
S.a. 3475 
 
 
X X X X X -8X 9.1x10 1.1x10-7 1.3x10-6
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PCR Analyses of mupA and Conjugative Transfer Genes  
 The presence or absence of mupA, nes, traA, and traK PCR products in staphylococcal 
strains is summarized in Table 12.  The presence of the mupA gene was consistent with the 
phenotypic level of mupirocin resistance in that all 33 strains that displayed high-level mupirocin 
resistance showed a PCR product corresponding to the expected size of the mupA gene and all 10 
strains lacking a PCR product were either susceptible or had low-level resistance.  The PCR 
assay for the rpoB (RNA polymerase, β-subunit) gene was intended as a positive control to 
determine whether the DNA preparations yielded PCR-quality DNA.  A positive control was 
necessary because some strains were expected to lack PCR products for the mupA and 
conjugative transfer genes. The rpoB gene was chosen as a positive control because Drancourt 
and Raoult (2002) showed that the rpoB gene could be used to determine relatedness among 
staphylococcal species.  However, rpoB did not result in a PCR product on multiple attempts for 
five S. epidermidis and two S. aureus strains that were determined to be effective PCR substrates 
using other primer pairs.   
 Analysis of the three essential conjugative transfer genes (nes, traA, and traK) confirmed 
the hypothesis that strains capable of serving as donors possessed all three genes with expected 
size PCR products.  All 13 capable donors that were assayed contained full-length copies of nes, 
traA, and traK PCR products.  In contrast, strains incapable of serving as donors (all naturally-
occurring S. epidermidis and recently isolated S. aureus) had various combinations of 
presence/absence of PCR products of the three transfer genes, although none of the non-capable 
donors possessed all three of the transfer genes.  Nine incapable donors failed to amplify PCR 
products corresponding to the three conjugative transfer genes; 11 strains lacked nes and traA 
PCR products but a full-length copy of the traK product was present; one strain amplified PCR 
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products of nes and traA but did not possess a traK product; and one strain failed to amplify traA 
and traK  products but had a full-length copy of the nes product.  Table 13 presents a summary 
of PCR analysis of the conjugative transfer genes. 
  
 
Table 12 Results From PCR Assay of mupA, nes, traA, and traK Genes.  H = high-level mupirocin-resistant phenotype; S = sensitive to 
mupirocin; “+” represents the presence of PCR product; “-“  represents the absence of PCR product; nd = not done, √ = successful 
donor, X = non-capable donor 
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Table 12 continued Results From PCR Assay of mupA, nes, traA, and traK Genes.  H = high-level mupirocin-resistant phenotype; S = 
sensitive to mupirocin; “+” represents the presence of PCR product; “-“  represents the absence of PCR product; nd = not done, √ = 
successful donor, X = non-capable donor 
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Table 13 Presence and Absence of full-length PCR Products From Non-capable Donors for 
Three Genes Essential for Conjugative Transfer.  “√” represents presence of a PCR product 
corresponding to the gene of interest.  “X” represents the absence of a full-lenth PCR product 
that corresponded to the gene of interest 
 Number of non-
capable donors Gene  
 nes traA traK  
√ X X 1  
X X √ 11  
√ √ X 1  
X X X 12  
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CHAPTER 4 
DISCUSSION 
 
Interspecific Transfer from S. epidermidis Donors  
 Reports on the ability of S. epidermidis to successfully donate antibiotic resistance 
determinants via conjugation have varied depending on the specific resistance being assessed.  
However, even among investigators interested in a common resistant determinant, 
transmissibility from S. epidermidis donors has ranged from reports of transmissibility in some 
strains to complete non-transmissibility in all isolates assayed.  For example, analysis of 
conjugative transfer of gentamicin resistance has been the most comprehensive resistance 
studied in staphylococci.  Archer and Johnston (1983) reported the transfer of gentamicin 
resistance from clinical S. epidermidis isolates to a S. aureus recipient in 50% of the attempted 
conjugations (9 of 18).  In an attempt to mimic the environment on human skin, Jaffe et al. 
(1980) also confirmed transfer of gentamicin resistance in vitro using incubations of donor and 
recipient strains in a medium containing lysozyme.  Reports of non-transmissibility of 
gentamicin resistance in naturally-occurring S. epidermidis are also common.  Zorbas et al. 
(1988) and Rogolsky and Gobert (1990) found transfer of gentamicin resistance unattainable 
from twenty-four S. epidermidis donors to S. aureus recipients.  In a study whose results were 
consistent with the current study on high-level mupirocin resistance, Udo et al. (1992) found that 
S. epidermidis transconjugants were capable of donating gentamicin resistance to S. aureus 
recipients while naturally-occurring strains were incapable of serving as donors. 
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Transfer of Mupirocin Resistance Interspecifically 
 Although intra- and interspecifically conjugative transfer of high-level mupirocin 
resistance from naturally-occurring S. aureus donors has been demonstrated to frequently occur, 
there have been few studies addressing the ability of naturally-occurring S. epidermidis strains to 
transfer high-level mupirocin resistance intra- and interspecifically.  Transconjugants of S. 
epidermidis have consistently demonstrated the ability to donate mupirocin resistance to both S. 
epidermidis and S. aureus recipients (Bastos et al. 1999; Thomas et al. 1999).  While several 
studies make reference to the potential for S. epidermidis to serve as a reservoir for resistance, it 
is unclear whether transmission from naturally-occurring isolates readily occurs, at least in vitro.  
The single report of transfer of high-level mupirocin resistance from naturally-occurring strains 
involved an in vivo study of one patient who was a persistent carrier of mupirocin-susceptible 
MRSA (Hurdle et al. 2005).  Cultures taken from the nares prior to the start of prophylaxis 
treatment with mupirocin, included mupirocin-sensitive MRSA and mupirocin-resistant S. 
epidermidis.  In the course of prophylaxis with mupirocin ointment, a single high-level 
mupirocin-resistant MRSA emerged in the nares.  The mupirocin-resistant MRSA and 
mupirocin-resistant S. epidermidis strains were found to possess identical plasmids leading to the 
conclusion that horizontal gene exchange had occurred.  Transfer in vitro from S. epidermidis to 
S. aureus occurred at low rates (10-9 per donor cell).  The finding suggests that transfer of high-
level mupirocin resistance from naturally-occurring S. epidermidis donors to S. aureus recipients 
occurs so infrequently (given the low rate of transfer in vitro and the emergence of a single 
mupirocin-resistant MRSA in vivo) that it may be undetectable in typical in vitro experiments. 
 Because S. epidermidis is the most commonly isolated CNS and frequently shares an 
ecological niche with S. aureus, the potential for conjugative transfer of high-level mupirocin 
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resistance in other CNS has rarely been included when testing for resistance reservoirs.  Transfer 
of high-level mupirocin resistance by filter mating from a single S. haemolyticus donor to other 
CNS recipients (S. heamolyticus, S. saprophyticus, and S. epidermidis) and to a restriction-
deficient S. aureus recipient was reported by Udo et al. (1997).  However, the S. haemolyticus 
donor was incapable of transferring high-level mupirocin resistance to a restriction-proficient S. 
aureus recipient. 
 
Explanations for Non-transmissibility 
 Strains identified in the current study as non-capable donors of high-level mupirocin 
resistance include all 23 S. epidermidis isolates and 3 recently (post 2004) isolated S. aureus 
strains.  One explanation for interspecific non-transmissibility may be significant genetic 
variability that results in non-recognition between donors and recipients.  If that were the case, 
the conjugative pilus would not be expected to extend to the recipient and cell-to-cell contact 
would not occur.  However, conjugation was possible from S. aureus donors to S. epidermidis 
recipients and, therefore, this observation would require a one-directional explanation, that is, 
the S. aureus pilus can recognize S. epidermidis but the S. epidermidis pilus cannot recognize S. 
aureus.  Also, S. epidermidis non-transmissibility was observed intraspecifically; therefore, it is 
unlikely that non-recognition is an adequate explanation for non-transmissibility within S. 
epidermidis. 
 Restriction-modification systems represent another potential explanation for both inter-
and intraspecific non-transmissibility.  The presence of restriction enzymes in recipient strains 
may cleave and degrade donor DNA before it is replicated and modified in the recipient cell or 
before it is incorporated into the genome of the recipient.  The observation that high-level 
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mupirocin resistance was not transmissible from several donors when using a restriction-
deficient recipient strain (S. aureus ATCC 35556) renders restriction enzymes an improbable 
explanation.   
 
Conjugative Transfer Genes 
 The apparent absence of essential conjugative transfer genes supports the hypothesis that 
the cause of non-transmissibility is most likely a consequence of deficiencies in transfer capacity 
in the non-capable donors.  Genes encoding proteins required for conjugative transfer represents 
a potential source of explanation for the non-transmissible phenomenon.  Successful conjugative 
transfer in Staphylococcus is contingent upon the presence of full-length copies of fifteen 
essential transfer genes (tra genes).  The absence of a full-length copy of one or more essential 
transfer genes was hypothesized to explain the observed non-transmissible form of high-level 
mupirocin resistance in S. epidermidis and recent S. aureus donors.  Staphylococcal conjugative 
transfer genes have been characterized in a class of well-described plasmids that are prevalent in 
North American staphylococci.  One member of this plasmid class is pG01, a 52 kb plasmid, that 
encodes resistance to aminoglycosides, trimethoprim, and quaternary ammonium compounds 
(Archer and Scott 1991).  Observation of a conjugative mupirocin resistance plasmid that was 
incompatible with pG01 led to the description of pG0400 (Morton et al. 1995) as a distinct 
plasmid.  The plasmids pG01 and pG0400 are identical except for the presence in pG0400 of 
mupirocin resistance.  The essential conjugative transfer genes have been found to reside on 
homologous 14.5 kb Bgl II fragments of pG01 and pG0400 (Thomas and Archer 1989).  
Deletions, insertions, and recombinations within the 14.5 kb fragment resulted in non-
transmissibility (Archer and Scott 1991).  Archer and Scott (1991) analyzed S. aureus and CNS 
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from various geographical locations in the United States using a 6.2 kb EcoR I fragment 
corresponding to a region of the conjugative transfer genes.  A higher percentage of S. aureus 
than S. epidermidis strains hybridized with the probe (27% versus 11.5%, respectively).  
Moreover, of the probe-positive strains, a higher percentage of S. aureus (91.5%) transferred 
resistances in filter matings than did probe-positive S. epidermidis (65%).  In two probe-positive 
but non-transmissible S. epidermidis the entire transfer region was found to have integrated into 
the chromosome.  Rogolsky and Gobert (1990) also observed non-transmissibility in S. 
epidermidis in regards to gentamicin resistance.  Analysis of the conjugative transfer genes using 
a 6.3 kb (EcoR I and Xba I digests) probe resulted in the conclusion that non-transmissibility was 
due to deletions or recombinations in the tra genes, and in one case, an excess of tra genes led to 
non-transmissibility.  
 
Conclusions 
PCR analysis of three essential conjugative transfer genes (nes, traA, and traK) 
confirmed that all capable donors possessed full-length PCR products corresponding to the three 
genes transfer genes.  Incapable donors included both S. epidermidis and S. aureus showed 
variability in the presence/absence of the three genes with no incapable donor possessing all 
three transfer genes.  Nine incapable donors lacked all three conjugative transfer genes; eleven 
strains lacked two of the genes but had a full length copy of one transfer gene; and two strains 
had full length copies of two conjugative transfer genes but did possess one transfer gene.  The 
genetic differences among non-capable donors suggest that non-transmissibility has arisen 
independently in different strains via gene deletions and recombinations. 
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 The use of the gene that encodes the RNA polymerase, β-subunit (rpoB) as a positive 
control was predicated on a report of its utility as a sequence-based genus-specific identification 
marker of staphylococcal species (Drancourt and Raoult 2002).  However, in the current study 
locally isolated strains of S. aureus and S. epidermidis showed variation in the presence/absence 
of the rpoB gene product.  Sequence variation in primer sites among strains from diverse 
geographical location could account for the discrepancy because Drancourt and Raoult (2002) 
surveyed staphylococcal strains isolated in France. 
 The hypothesis that S. epidermidis can serve as a resistance reservoir has clinical 
implications because S. epidermidis is a commensal of human skin and is frequently exposed to 
antibiotics not targeted toward S. epidermidis.  Although mupirocin prescriptions have been 
administratively controlled for several years at the VAMC and VAMC-NH and mupirocin 
resistance is currently low in S. aureus (Walker et al. 2004), the re-emergence of mupirocin 
resistance in S. aureus could occur via gene exchange with a reservoir species.  Thus, the current 
study confirms the importance of surveillance of potential resistance reservoirs. 
 The development and research of antibiotics such as vancomycin and teicoplanin, which 
are directed toward MRSA infections, should analyze naturally-occurring resistance in S. 
epidermidis and horizontal gene exchange inter- and intraspecifically in Staphylococcus.  Only a 
comprehensive examination of Staphylococcus, including resistance reservoirs and gene 
exchange, can adequately assess the potential emergence of resistance to newer antibiotics. 
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APPENDIX 
Conjugative Transfer Rates 
 
Conjugative Transfer Rates for Donor-Recipient Combinations Involing S. aureus and S. 
epidermidis.  S.a.= S. aureus, S.e.=S. epidermidis, TC= S. epidermidis transconjugant having 
received high-level mupirocin resistance from S. aureus 
  
Donor x Recipient Rate 
-7S.a. 3570-1 x S.a. 2782-22 1.01 x 10
52 
 
 
 
S.a. 3570-1 x S.a. 22B1 7.02 x 10-7
-7S.a. 3570-1 x S.a. ATCC 35556 4.63 x 10
S.a. 3570-1 x S.e. 5A1 3.77 x 10-6
S.a. 3570-1 x S.e 27A2 1.05 x 10-7
S.a. 3475 x S.a. 2782-22 1.13 x 10-7
8.59 x 10-9 
S.a. 3475 x 22B1 4.88 x 10-8
9.38 x 10-7
S.a. 3475 x S.a. ATCC 35556 5.31 x 10-7
2.01 x 10-7
S.a 3475 x S.e. 5A1 2.25 x 10-8
7.99 x 10-7
-6S.a. 3475 x S.e. 27A2 3.03 x 10
S.a. 2782-1 x S.e. 5A1 1.52 x 10-6
S.a. 2782-1 x S.e. 27A2 1.68 x 10-7
-9S.a. 4431 x S.a. 22B1 1.14 x 10
-8S.a. 4431 x S.e. 5A1 8.10 x 10
-8S.a. 5023 x S.a. 22B1 1.03 x 10
-7S.a. 5023 x S.e. 5A1 7.53 x 10
-8S.e. 5A1TC x S.a. 11B1 3.76 x 10
-8S.e. 5A1TC x S.e. 30B1 5.15 x 10
-8S.e. 27A2TC x S.a. 11B1 6.67 x 10
-6S.e. 27A2TC x S.e. 30B1 1.53 x 10
-6S.e. 30B1 TC2 x S.a. 2782-22 2.61 x 10
S.e. 30B1 TC2 x S.e. 5A1 5.02 x 10-6
S.e. 30B1 TC2 x S.e. 27A2 8.88 x 10-6
53 
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